USPTO serial 88937124
RX PLUS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FICKES, JERI J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RX PLUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chuo-ku, Tokyo, JP
Chuo-ku, Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christian S. Morgan
Christian S. Morgan Baker & McKenzie LLP300 E. Randolph StreetSuite 5000Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology-related conditions and disorders, arrhythmia and bile duct conditions and disorders | ACTIVE | — |
| 009 | Downloadable medical software for processing and displaying images on ultrasound medical imaging machines; downloadable computer software for controlling and managing patient medical information; downloadable medical software for processing and displaying affected part images on medical resonance imaging machines (MRIs); downloadable software for medical imaging equipment, namely, for interpreting the results of CT scanners; downloadable computer programs for use in the operation of medical ultrasound detectors; downloadable computer software for medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology-related conditions and disorders, arrhythmia and bile duct conditions and disorders and for conducting medical diagnostic testing | ACTIVE | — |
| 010 | Medical apparatus for detection and treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology-related conditions and disorders, arrhythmia and bile duct conditions and disorders, and for diagnostic imaging | ACTIVE | — |
| 041 | Instruction in the field of dosage management; entertainment services, namely, providing online computer games; providing therapeutic exercise instruction; sports club services, namely, physical fitness instruction | ACTIVE | — |
| 042 | Providing temporary use of on-line non-downloadable computer programs for use in medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology-related conditions and disorders, arrhythmia and bile duct-related conditions and disorders; research and development services in the scientific or medical field; providing scientific research information in the field of clinical trials | ACTIVE | — |
| 044 | Medical services; medical diagnostic testing services; surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology-related conditions and disorders, arrhythmia and bile duct related conditions and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Astellas Pharma Inc.
- Other trademarks owned by Astellas Pharma Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RX PLUS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 17, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 13, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 8, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 8, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 28, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 28, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 28, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 21, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 19, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 19, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 19, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 3, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 3, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 3, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 18, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 17, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 17, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 10, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 10, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 10, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 10, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 10, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 10, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 10, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 10, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 6, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 4, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 4, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 4, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 11, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 6, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 1, 2020 | NWAP | NEW APPLICATION ENTERED | — |